Technology News and Research

RSS

$The immune responses and safety of fractional third-doses of heterologous COVID-19 vaccines after CoronaVac primary series$

The immune responses and safety of fractional third-doses of heterologous COVID-19 vaccines after CoronaVac primary series

Researchers evaluated the vaccine effectiveness of half-doses of AZD1222 or BNT162b2 COVID-19 vaccines as a booster dose following primary series vaccination with CoronaVac.

6 Oct 2022

The neuroprotective potential of Cannabis sativa L. against Alzheimer's disease

A recent study assesses the neuroprotective potential of the active constituents of cannabis in treating dementia and Alzheimer's disease.

6 Oct 2022

Labskin to develop new revolutionary approach to testing for radiation exposure

Labskin is delighted to announce our selection by The Intelligence Advanced Research Projects Activity (IARPA), part of the US Office of the Director of National Intelligence, to join a team of experts to develop new ways to evaluate radiation exposure in civilians and military personnel.

6 Oct 2022

Interactions with a dog lead to increasingly higher levels of prefrontal brain activity

Researchers led by Rahel Marti at the University of Basel in Switzerland report that viewing, feeling, and touching real dogs leads to increasingly higher levels of activity in the prefrontal cortex of the brain.

5 Oct 2022

CMU Array holds potential to transform how doctors treat neurological disorders

Carnegie Mellon University researchers have pioneered the CMU Array - a new type of microelectrode array for brain computer interface platforms.

5 Oct 2022

Key biophysical attributes of a self-amplifying viral RNA vaccine developed for SARS-CoV-2

Researchers used various analytical characterization techniques to determine the biophysical attributes of the Imperial College London self-amplifying viral RNA vaccine (IMP-1) developed for SARS-CoV-2.

5 Oct 2022

Smartphone App could help advance the early detection of Parkinson's disease and severe COVID-19

A new screening test App could help advance the early detection of Parkinson's disease and severe COVID-19, improving the management of these illnesses.

5 Oct 2022

New project secures NIH funding to tackle chronic health disparities

Chronic diseases such as diabetes, heart disease and cancer disproportionally affect racial and ethnic minorities.

5 Oct 2022

Study reveals the determinants of persistent and severe COVID-19

As COVID-19 wreaks havoc across the globe, one characteristic of the infection has not gone unnoticed. The disease is heterogeneous in nature with symptoms and severity of the condition spanning a wide range.

5 Oct 2022

Star-shaped brain cells can "turn off" neurons involved in heroin relapse

Neuroscientists from the Medical University of South Carolina report in Science Advances that star-shaped brain cells known as astrocytes can "turn off" neurons involved in relapse to heroin.

5 Oct 2022

Nursing home surprise: Advantage plans may shorten stays to less time than Medicare covers

After 11 days in a St. Paul, Minnesota, skilled nursing facility recuperating from a fall, Paula Christopherson, 97, was told by her insurer that she should return home.

4 Oct 2022

The Increasing Use of Microfluidics in Labs and Hospitals

This interview from Bartels discusses how microfluidics will be used increasingly in labs, hospitals and doctors offices in the future. Bartels provides its clients with fast and easy entry into the microfluidics field.

From Bartels Mikrotechnik GmbH 4 Oct 2022

Daxor's BVA-100 diagnostic blood test reduces hospital length of stay for heart failure patients

Daxor Corporation, the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company's BVA-100 diagnostic blood test in reducing hospital length of stay (LOS) for heart failure (HF) patients.

3 Oct 2022

New data validates the benefits of Daxor's BVA-100 blood test for heart failure patients

Daxor Corporation, the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company's BVA-100 blood test for heart failure patients. Data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2022 – which brought together the world's leading experts in heart failure from September 30th thru October 3rd, 2022, in Washington, DC.

3 Oct 2022

Technology News and Research

The immune responses and safety of fractional third-doses of heterologous COVID-19 vaccines after CoronaVac primary series

The neuroprotective potential of Cannabis sativa L. against Alzheimer's disease

Labskin to develop new revolutionary approach to testing for radiation exposure

Interactions with a dog lead to increasingly higher levels of prefrontal brain activity

CMU Array holds potential to transform how doctors treat neurological disorders

Key biophysical attributes of a self-amplifying viral RNA vaccine developed for SARS-CoV-2

Smartphone App could help advance the early detection of Parkinson's disease and severe COVID-19

New project secures NIH funding to tackle chronic health disparities

Study reveals the determinants of persistent and severe COVID-19

Star-shaped brain cells can "turn off" neurons involved in heroin relapse

Nursing home surprise: Advantage plans may shorten stays to less time than Medicare covers

The Increasing Use of Microfluidics in Labs and Hospitals

Daxor's BVA-100 diagnostic blood test reduces hospital length of stay for heart failure patients

New data validates the benefits of Daxor's BVA-100 blood test for heart failure patients

Understanding the link between stiffness in triceps surae and passive stiffness of ankle joint

UPC's engineering students design a customizable transradial prosthesis using 3D printing

Collaboration aims to investigate ARTIDIS technology as novel treatment-optimization tool for solid tumors

New cell-free protein crystallization method: A major headway in the field of structural biology

Optibrium strengthens global AI drug discovery software operations with three key appointments

Universal vaccine advancement through AI and recombinant technology

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News